A dual-chamber model of the female genital tract to evaluate epithelial toxicity of candidate anti-HIV microbicides

Current Protocols in Cell Biology

Volumn , Issue SUPPL. 52, 2011, Pages

  Ariën, Kevin K ^a   Vanham, Guido ^a   Gali, Youssef ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Female genital tract; HIV; Microbicides; Sexual transmission; Toxicity

Indexed keywords

ANTIRETROVIRUS AGENT; MICROBICIDE;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINE; CELL VIABILITY; CLINICAL PROTOCOL; CYTOTOXICITY; DENDRITIC CELL; DRUG ACTIVITY; ENDOMETRIUM; FEMALE GENITAL SYSTEM; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; MACROPHAGE; MICROSCOPY; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; THAWING; UTERINE CERVIX EPITHELIUM; VAGINA EPITHELIUM; VIRION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 82455192407     PISSN: 19342500     EISSN: 19342616     Source Type: Journal    
DOI: 10.1002/0471143030.cb2613s52     Document Type: Article

References (33)

1. Adler, K., Erickson, T., and Bobrow, M. 1997. High sensitivity detection of HPV-16 in SiHa and CaSki cells utilizing FISH enhanced by TSA. Histochem. Cell Biol. 108:321-324.
2. Ariën,K.K., Jespers,V., andVanham, G. 2011. HIV sexual transmission andmicrobicides. Rev. Med. Virol. 21:110-133.
3. Baker, C.C., Phelps, W.C., Lindgren, V., Braun, M.J., Gonda, M.A., and Howley, P.M. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962-971.
4. Beer, B.E., Doncel, G.F., Krebs, F.C., Shattock, R.J., Fletcher, P.S., Buckheit, R.W. Jr., Watson, K., Dezzutti, C.S., Cummins, J.E., Bromley, E., Richardson-Harman, N., Pallansch, L.A., Lackman-Smith, C., Osterling, C., Mankowski, M., Miller, S.R., Catalone, B.J., Welsh, P.A., Howett, M.K., Wigdahl, B., Turpin, J.A., and Reichelderfer, P. 2006. In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: A retrospective analysis of results from five laboratories. Antimicrob. Agents Chemother. 50:713-723.
5. Blocker, M.E. and Cohen, M.S., 2000. Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus. Infect. Dis. Clin. N. Am. 14:983-999.
6. Coombs, R.W., Reichelderfer, P.S., and Landay, A.L. 2003. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 17:455-480.
7. Cutler, B. and Justman, J. 2008. Vaginal microbicides and the prevention of HIV transmission. Lancet Infect. Dis. 8:685-697.
8. Dezzutti, C.S., Guenthner, P.C., Cummins, J.E. Jr., Cabrera, T., Marshall, J.H., Dillberger, A., and Lal, R.B. 2001. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J. Infect. Dis. 183:1204-1213.
9. Elias, C.J. andCoggins,C. 1996. Female-controlled methods to prevent sexual transmission of HIV. AIDS 10:S43-S51.
10. Fichorova, R.N., Rheinwald, J.G., and Anderson, D.J. 1997. Generation of papillomavirus immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol. Reprod. 57:847-855.
11. Fichorova, R.N., Tucker, L.D., and Anderson, D.J. 2001. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J. Infect. Dis. 184:418-428.
12. Fichorova, R.N., Bajpai, M., Chandra, N., Hsiu, J.G., Spangler,M., Ratnam,V., andDoncel,G.F. 2004. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol. Reprod. 71:761-769.
13. Fichorova, R.N., Zhou, F., Ratnam, V., Atanassova, V., Jiang, S., Strick, N., and Neurath, A.R. 2005. Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation. Antimicrob. Agents Chemother. 49:323-335.
14. Furuta, Y., Eriksson, K., Svennerholm, B., Fredman, P., Horal, P., Jeansson, S., Vahlne, A., Holmgren, J., and Czerkinsky, C. 1994. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc. Natl. Acad. Sci. U.S.A. 91:12559-12563.
15. Gali, Y., Ariën, K.K., Praet, M., Van den Bergh, R., Temmerman, M., Delezay, O., and Vanham, G. 2010a. Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity. J. Virol. Methods 165:186-97.
16. Gali, Y., Delezay, O., Brouwers, J., Addad, N., Augustijns, P., Bourlet, T., Hamzeh-Cognasse, H., Ariën, K.K., Pozzetto, B., and Vanham, G. 2010b. In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides. Antimicrob. Agents Chemother. 54:5105-5114.
17. Herold, B.C., Mesquita, P.M., Madan, R.P., and Keller, M.J. 2011. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections. Am. J. Reprod. Immunol. 65:325-333.
18. Hillier, S.L., Moench, T., Shattock, R., Black, R., Reichelderfer, P., and Veronese, F. 2005. In vitro and in vivo: The story of nonoxynol 9. J. Acquir. Immune Defic. Syndr. 39:1-8.
19. Kuramoto, H., Tamura, S., and Notake, Y. 1972. Establishment of a cell line of human endometrial adenocarcinoma in vitro.Am. J. Obstet.Gynecol. 114:1012-1019.
20. Li, Q., Estes, J.D., Schlievert, P.M., Duan, L., Brosnahan, A.J., Southern, P.J., Reilly, C.S., Peterson, M.L., Schultz-Darken, N., Brunner, K.G., Nephew, K.R., Pambuccian, S., Lifson, J.D., Carlis, J.V., and Haase, A.T. 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458:1034-1038.
21. Losikoff, P., Fichorova, R., Snyder, B., Rodriguez, I., Cu-Uvin, S., Harwell, J., and Mayer, K.H. 2007. Genital tract interleukin-8 but not interleukin-1β or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIVuninfected women. Infect. Dis. Obstet. Gynecol. 2007:92307.
22. Narimatsu, R., Wolday, D., and Patterson, B.K. 2005. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res. Hum. Retrovir. 21:228-233.
23. Nicolosi, A., Corrêa Leite, M.L., Musicco, M., Arici, C., Gavazzeni, G., and Lazzarin, A. 1994. The efficiency of male-to-female and female-tomale sexual transmission of the human immunodeficiency virus: A study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology 5:570-575.
24. Poonia, B., Wang, X., and Veazey, R.S. 2006. Distribution of simian immunodeficiency virus target cells in vaginal tissues of normal rhesus macaques: Implications for virus transmission. J. Reprod. Immunol. 72:74-84.
25. Pope, M. 2003. Dendritic cells as a conduit to improve HIV vaccines. Curr. Mol. Med. 3:229-242.
26. Pudney, J., Quayle, A.J., and Anderson, D.J., 2005. Immunological microenvironments in the human vagina and cervix: Mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 73:1253-1263.
27. Reuter, S., Delius, H., Kahn, T., Hofmann, B., zur Hausen, H., and Schwarz, E. 1991. Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell lineME180. J. Virol. 65:5564-5568.
28. Shen, R., Richter, H.E., Clements, R.H., Novak, L., Huff, K., Bimczok, D., Sankaran-Walters, S., Dandekar, S., Clapham, P.R., Smythies, L.E., and Smith, P.D. 2009. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J. Virol. 83:3258-3267.
29. Sugaya, M., Lore, K., Koup, R.A., Douek, D.C., andBlauvelt, A. 2004. HIV-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within Langerhans cell-T cell clusters. J. Immunol. 172:2219-2224.
30. Tan, X. and Phillips, D.M. 1996. Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus. Arch. Virol. 141:1177-1189.
31. Shattock, R.J. and Moore, J.P. 2003. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1:25-34.
32. Van Damme, L., Ramjee, G., Alary, M., Vuylsteke, B., Chandeying, V., Rees, H., Sirivongrangson, P., Tshibaka, L.M., Etti'egne-Traoré, V., Uaheowitchai, C., Karim, S.S.A., Mâsse, B., Perriëns, J., and Laga, M. 2002. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 360:971-977.
33. Wei, X., Decker, J.M., Wang, S., Hui, H., Kappes, J.C., Wu, X., Salazar-Gonzalez, J.F., Salazar, M.G., Kilby, J.M., Saag,M.S., Komarova, N.L., Nowak, M.A., Hahn, B.H., Kwong, P.D., and Shaw, G.M. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.